Regulation & Compliance

A new partnership between Health Impact Alliance and Infineon promises to keep seniors independent longer using advanced chips, Wi-Fi 6, and edge AI.

A new AI-powered scanner promises to capture data from badges, business cards, and even conversations, transforming event ROI but raising privacy questions.

T. Rowe Price's private credit fund posts a 10.6% distribution rate, but a drop in net asset value and negative earnings raise deeper questions.

Despite a dip in net income, the BDC maintains its dividend and executes accretive buybacks, signaling a focus on shareholder value in a tough market.

As private practices vanish, one AI firm is injecting $20 billion to help independent doctors fight back against consolidation. But can it work?

Arq reports higher Q1 revenue but a net loss due to GAC charges. The company reaffirms guidance, banking on its profitable core business and new ventures.

Despite flat gas production, Montauk leverages environmental credits for a 9% revenue jump and secures $200M to fuel its strategic shift to agriculture.

LifeMD posts record subscriber growth in Q1 driven by GLP-1 and women's health, but a planned loss from heavy marketing spend raises key questions.

Nitro's new MCP connector for Claude AI promises to automate complex document tasks with a single prompt, targeting a major productivity pain point in enterprise AI.

The partnership merges top-tier consulting with a leading AI platform, promising a new era of fairer, data-driven compensation for global enterprises.

As DOJ deadlines loom and ADA lawsuits surge, a new player offers automated tools to tackle the immense challenge of making millions of PDFs accessible.

A beloved nursing home, destroyed in the Eaton Fire, sues SoCal Edison, claiming the utility's negligence left 45 vulnerable residents permanently displaced.

Love Island's Tasha Ghouri launches ASHA, a resort wear brand with a mission, using EnableAll tech to make fashion truly accessible for the deaf community.

The legal tech leader will showcase its new AI agent, built with Boomi, at Boomi World 2026 to automate lockbox processing and boost financial efficiency.

RVL Pharmaceuticals claims double-digit growth for its eye drop Upneeq, but as a private firm, its disruptive direct-to-consumer model operates outside public view.

With a promising cancer pipeline, Crescent Biopharma heads to key May conferences to prove its strategy against fierce competition in the bispecific and ADC markets.

A Marine veteran and stand-up comedian is running for Congress in Florida. Can Tim Wilkins' outsider campaign and conservative platform win over a key district?

A new platform, Katon Meet, promises unlimited video meetings for free, aiming to disrupt Zoom and Google. But can this 'equal access' promise last?

New performance metrics have been proposed to reform a federal rule that threatens to decertify nearly half of U.S. organ procurement organizations.

A new partnership delivers a turnkey, on-premises AI solution, letting firms in healthcare and government harness AI without compromising data privacy.